Infusional etoposide, cyclophosphamide, vincristine, doxorubicin, and prednisone +/- rituximab as first-line therapy for aggressive non-Hodgkin lymphoma

INTRODUCTION: Dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA-EPOCH) was developed in an effort to overcome inadequate drug concentrations and to compensate for increased drug clearance. The goal of this study was to examine risk factors and outcomes in patient...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Lymphoma Myeloma Leuk
Main Authors: Lamar, Zanetta S., Fino, Nora, Palmer, Jodi, Gruber, Lindsey, Morris, Bonny B., RaetskayaSolntseva, Olga, Kennedy, LeAnne, Vaidya, Rakhee, Hurd, David, Zamkoff, Kenneth
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4731284/
https://ncbi.nlm.nih.gov/pubmed/26725264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2015.11.012
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker